3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Cyclophosphamide
16
Rituximab
14
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
fludarabine phosphate
7
fludarabine
7
Specimen Handling
7
Prednisone
7
Etoposide
6
Biopsy
6
tocilizumab
5
polatuzumab vedotin
5
ibrutinib
5
X-Rays
5
Whole-Body Irradiation
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Lenalidomide
5
Doxorubicin
5
Mycophenolic Acid
4
Cytarabine
4
Cyclosporine
4
Busulfan
4
venetoclax
3
pembrolizumab
3
glofitamab
3
acalabrutinib
3
Vincristine
3
Tacrolimus
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
parsaclisib
×
30 days
×
Clear all
NCT04661007
2026-05-18
J-MIND
Incyte Corporation
Phase 1/2
Active not recruiting
72 enrolled